Table 1 Peptide sequence used in this study
Name | Sequence | Amino acid position | Reference |
---|---|---|---|
ESAT61 | MTEQQ WNFAG IEAAA SAIQG | 1–20 | |
IQG NVTSI HSLLD EG | 18–32 | ||
NVTSI HSLLD EGKQS | 21–35 | ||
MTEQQ WNFAG IEAAA SAIQG NVTSI HSLLD EGKQSL *EE | 1–36 |  | |
ESAT62 | TAT ELNNA LQNLA RT | 61–75 | |
NNA LQNLA RTISE AG | 66–80 | ||
A RTISE AGQAM ASTE | 73–87 | ||
LQNLA RTISE AGQAM ASTEG NV | 71–90 | ||
DATAT ELNNA LQNLA RTISE AGQAM ASTEG NVTGM F EE | 59–94 |  | |
CFP101 | GSLQG QWRGA AGTAA | 37–51 | |
G QWRGA AGTAA QAAV | 41–55 | ||
AAVV RFQEA ANKQK Q | 53–67 | ||
V RFQEA ANKQK QELD | 56–70 | ||
GSLQG QWRGA AGTAA QAAVV RFQEA ANKQK QELDE I EE | 37–72 |  | |
CFP102 | AANKQ KQELD EISTN | 61–75 | |
KQELD EISTN IRQAG | 66–80 | ||
EISTN IRQAG VQYSR | 71–85 | ||
IRQAG VQYSR ADEEQ | 76–90 | ||
VQYSR ADEEQ QQALS | 81–95 | ||
AANKQ KQELD EISTN IRQAG VQYSR ADEEQ QQALS S | 61–96 |  | |
Rv2031c | RTE QKDFD GRSEF AYGSF VR | 81–100 | |
SEF AYGSF VRTVS LPVGA DE | 91–110 | ||
TVS LPVGA DEDDI K | 101–114 | ||
AERTE QKDFD GRSEF AYGSF VRTVS LPVGA DEDDI K EE | 79–114 |  |